A prospective randomized, double blind, placebo controlled study to evaluate the safety, tolerability and pharmacokinetics of ZYH1 following once a fay (OD) oral administrations up to 10 days in healthy volunteers

Authors
Category Primary study
JournalDiabetes
Year 2009
This article has no abstract
Epistemonikos ID: 0e9ff89fbf5b183478e018ea9be978c8a5ddd067
First added on: Feb 28, 2025